ANO1 and pulmonary arterial hypertension: However, given the fact that expression of TMEM16A in noninflamed human lungs is very low, but upregulated in the lungs of patients with asthma, CF, or pulmonary hypertension, the effects of potentiators or activators should be examined in the lungs of affected patients or in corresponding animal models [21,35,47,48].